Lupus & Connective Tissue Diseases
Conference Coverage
Long-term follow-up most important for hydroxychloroquine retinal screening
LIVERPOOL, ENGLAND – The cost of early screening for hydroxychloroquine eye toxicity is likely to be substantial if recent U.K. guidelines are...
Latest News
Cutaneous lupus: Switching antimalarials can delay immunosuppressive therapy
ORLANDO – A recent study of patients with cutaneous lupus found that about half of hydroxychloroquine nonresponders did respond to chloroquine.
Conference Coverage
Idiopathic pulmonary fibrosis a ‘robust diagnosis’
LIVERPOOL, ENGLAND – Very few patients with idiopathic pulmonary fibrosis have connective tissue antibodies, suggesting that IPF is a robust...
Conference Coverage
Hydroxychloroquine throws off Quantiferon-TB Gold results, study finds
Indeterminate test results can exclude patients from treatment with immunosuppressives and clinical trials.
Latest News
Timely dermatomyositis diagnosis, treatment remain elusive
Increased risk of cancer in DM, especially within 1-2 years of symptom onset, is the strongest argument for earlier diagnosis.
Conference Coverage
Median time to progression from discoid to systemic lupus may be less than a year
Investigators found that the median time to progression was shorter than the mean time to progression used in most studies.
Video
Don’t trust interface dermatitis to diagnose dermatomyositis
This histologic finding was not present in about a quarter of a cohort of patients with DM.
Conference Coverage
Caution crucial for stem cell transplant in scleroderma, despite potential interest
Long-term success of stem cell transplant in severe scleroderma patients might prompt patient interest, but most won’t be eligible, an expert says...
Conference Coverage
New agents may bring hope for SLE patients
SANDESTIN, FLA. – Dr. Michelle Petri describes promising drugs under investigation and goals for drug treatment for different patients with SLE....
Conference Coverage
Newer IgG4 testing proving effective in assessing patients
Interpreting IgG4 levels when determining whether patients have IgG4-related disease can be a tricky matter, but newer tests are effective tools...
Conference Coverage
VIDEO: Calming microglia might control fibromyalgia
SANDESTIN, FLA. – Dextronaltrexone, an isomer of the drug commonly employed in addiction medicine, might calm microglia and reduce fibromyalgia...